PH12497A - Novel n-aryl-n-(1-l-piperidinyl)-arylacetamides - Google Patents

Novel n-aryl-n-(1-l-piperidinyl)-arylacetamides

Info

Publication number
PH12497A
PH12497A PH18928A PH18928A PH12497A PH 12497 A PH12497 A PH 12497A PH 18928 A PH18928 A PH 18928A PH 18928 A PH18928 A PH 18928A PH 12497 A PH12497 A PH 12497A
Authority
PH
Philippines
Prior art keywords
arylacetamides
piperidinyl
aryl
novel
Prior art date
Application number
PH18928A
Other languages
English (en)
Inventor
S Sanczuk
H Hermans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PH12497A publication Critical patent/PH12497A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH18928A 1975-09-23 1976-09-22 Novel n-aryl-n-(1-l-piperidinyl)-arylacetamides PH12497A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (1)

Publication Number Publication Date
PH12497A true PH12497A (en) 1979-04-05

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
PH18928A PH12497A (en) 1975-09-23 1976-09-22 Novel n-aryl-n-(1-l-piperidinyl)-arylacetamides

Country Status (29)

Country Link
JP (1) JPS6016417B2 (fi)
AT (1) AT363935B (fi)
AU (1) AU510029B2 (fi)
BG (1) BG27543A3 (fi)
CA (1) CA1068271A (fi)
CH (1) CH628623A5 (fi)
CS (1) CS222663B2 (fi)
DE (1) DE2642856A1 (fi)
DK (1) DK150478C (fi)
ES (1) ES451768A1 (fi)
FI (1) FI61482C (fi)
FR (1) FR2325377A1 (fi)
GB (1) GB1539473A (fi)
GR (1) GR58469B (fi)
HU (1) HU172964B (fi)
IE (1) IE43802B1 (fi)
IL (1) IL50522A (fi)
IT (1) IT1073893B (fi)
LU (1) LU75837A1 (fi)
NL (1) NL187267C (fi)
NO (1) NO147672C (fi)
NZ (1) NZ181972A (fi)
PH (1) PH12497A (fi)
PL (2) PL117323B1 (fi)
PT (1) PT65631B (fi)
RO (1) RO70079A (fi)
SE (1) SE427839B (fi)
SU (1) SU747424A3 (fi)
YU (1) YU39973B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (ja) * 1986-05-08 1987-11-13 株式会社ヘキトク 燻瓦の製造ラインにおける焼成工程後の表面仕上げ装置
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
AU2008240727C1 (en) * 2007-04-23 2013-10-03 Janssen Pharmaceutica N.V. Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
CN101663292A (zh) 2007-04-23 2010-03-03 詹森药业有限公司 作为快速解离的多巴胺2受体拮抗剂的4-烷氧基哒嗪衍生物
CA2682671C (en) 2007-04-23 2015-11-17 Janssen Pharmaceutica N.V. Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
CN102159554B (zh) 2008-07-03 2014-09-24 詹森药业有限公司 作为5-ht6受体拮抗剂的取代的6-(1-哌嗪基)-哒嗪
LT2307374T (lt) 2008-07-31 2017-04-25 Janssen Pharmaceutica Nv Piperazin-1-il-trifluormetil-pakeistieji piridinai kaip greitai disocijuojantys dopamino 2 receptoriaus antagonistai

Also Published As

Publication number Publication date
GR58469B (en) 1977-10-14
FR2325377B1 (fi) 1980-04-18
HU172964B (hu) 1979-01-28
RO70079A (ro) 1982-10-26
LU75837A1 (fi) 1977-05-04
JPS5239683A (en) 1977-03-28
FI61482C (fi) 1982-08-10
NZ181972A (en) 1978-07-28
CH628623A5 (en) 1982-03-15
AU510029B2 (en) 1980-06-05
DE2642856C2 (fi) 1990-06-21
AU1787876A (en) 1978-03-23
PL192578A1 (pl) 1979-02-26
ES451768A1 (es) 1978-05-01
FI762698A (fi) 1977-03-24
NO763054L (no) 1977-03-24
JPS6016417B2 (ja) 1985-04-25
BG27543A3 (en) 1979-11-12
SU747424A3 (ru) 1980-07-23
CS222663B2 (en) 1983-07-29
NO147672C (no) 1983-05-25
FI61482B (fi) 1982-04-30
YU39973B (en) 1985-06-30
PL117323B1 (en) 1981-07-31
IL50522A (en) 1979-09-30
NL187267B (nl) 1991-03-01
IE43802B1 (en) 1981-06-03
SE427839B (sv) 1983-05-09
NL7610513A (nl) 1977-03-25
DK150478C (da) 1987-10-05
YU233676A (en) 1983-01-21
CA1068271A (en) 1979-12-18
IE43802L (en) 1977-03-23
IT1073893B (it) 1985-04-17
GB1539473A (en) 1979-01-31
PT65631A (en) 1976-10-01
ATA702976A (de) 1981-02-15
PT65631B (en) 1978-07-05
SE7610501L (sv) 1977-03-24
DK427876A (da) 1977-03-24
NL187267C (nl) 1991-08-01
DE2642856A1 (de) 1977-03-24
FR2325377A1 (fr) 1977-04-22
DK150478B (da) 1987-03-09
IL50522A0 (en) 1976-11-30
NO147672B (no) 1983-02-14
AT363935B (de) 1981-09-10

Similar Documents

Publication Publication Date Title
BG27526A4 (en) Herbicid antipoison
JPS5589279A (en) Novel dibenzopyrans
PT65688A (en) Novel 1-benzazolylalkyl-4-substituted-piperidines
JPS5190711A (en) Kanoshishinkohoyo tokunitonnerunainioite kanhogobanotatekomutamenomaeoshisochi
PT65631B (en) Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
CS188141B2 (en) Ski-brake
ZA765684B (en) Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS51105359A (en) Kanagatanokanetsu mataha reikyakuhoho
JPS5194822A (en) Shashinshoriekino saishoho
JPS5233692A (en) Novel cephlosporin
JPS5589280A (en) Novel dibenzopyrans
CS189776A2 (en) Zpusob regenerace paladiovych katalyzatoru
JPS51106969A (en) Sokosetsubiniokeru tanaoroshihoho
JPS51103896A (en) Nisuisetsukono seizohoho
JPS51105634A (en) Shadanbenniokeru bentaiseisosochi
BG27522A3 (en) Fungicœde compositiow
CH610841A5 (en) Skibob
JPS5187584A (en) Haipurasuchitsukuno netsubunkaisochi
JPS51106504A (en) Shimeshimizufuyono heibaninsatsugenban
JPS51103397A (en) Surooaueichitsupuno hooninguhoho
JPS5193710A (en) Mizogatajudoroto sonoseisanhoho
JPS51102579A (en) Handotaisochino seizohoho
JPS5180023A (en) Jokibentosono kudosochino yotaitono setsuzokukiko
JPS5183882A (en) Soarugontono gyoshukuki
JPS51106329A (en) Chujotaino tadanshinshukuhoho